Insider Trading History of Atlas Venture Associates Xi, Llc

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Atlas Venture Associates Xi, Llc since 2021. This trader's CIK number is 1780067. At the time of last reporting, Atlas Venture Associates Xi, Llc was the Officer of Dyne Therapeutics, Inc.. (stock ticker symbol DYN). Also see all insider trading activities at Dyne Therapeutics, Inc..

Note that in the past Atlas Venture Associates XI, LLC also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Day One Biopharmaceuticals, Inc. (DAWN) by Atlas Venture Associates Xi, Llc

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2021 DAWN 500,000 $8,000,000 0 $0 0 $0

Yearly summary of insider trading at Dyne Therapeutics, Inc. (DYN) by Atlas Venture Associates Xi, Llc

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2024 DYN 0 $0 510,152 $11,972,858 0 $0


Insider trading activities at 2 companies by Atlas Venture Associates Xi, Llc:

1. Day One Biopharmaceuticals, Inc. (DAWN)

2. Dyne Therapeutics, Inc. (DYN)

Table 1. Insider trading of Day One Biopharmaceuticals, Inc. (DAWN) by Atlas Venture Associates Xi, Llc

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2021-06-01 DAWN Buy 500,000 16.00 8,000,000

Table 2. Insider trading of Dyne Therapeutics, Inc. (DYN) by Atlas Venture Associates Xi, Llc

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2024-02-20 DYN Sale 169,539 23.05 3,908,721
2024-02-16 DYN Sale 162,707 23.14 3,765,039
2024-02-15 DYN Sale 177,906 24.16 4,299,098

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Atlas Venture Associates Xi, Llc (Officer of Dyne Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.